Cahill Represents Lead Arrangers in Acquisition Financing for Ortho-Clinical Diagnostics
Date: 06/30/14
Cahill represented Barclays Bank plc as administrative agent and lead arranger and the other lead arrangers in connection with a $2,175,000,000 Term B loan and a $350,000,000 revolving credit facility for Crimson Merger Sub, Inc. (to be merged with and into Ortho-Clinical Diagnostics, Inc.). The transaction was completed in connection with the acquisition of Ortho-Clinical Diagnostics, Inc. from Johnson & Johnson by private equity firm The Carlyle Group.
Earlier this year, Cahill also represented the joint book-running managers and the co-managers in connection with the Rule 144A offering of $1,300,000,000 aggregate principal amount of 6.625% Senior Notes due 2022 by Crimson Merger Sub, Inc., also in connection with the acquisition.